Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Testosterone therapy can improve sexual satisfaction and mood in surgically menopausal women when used with estrogen, but its long-term safety and effects on naturally menopausal and premenopausal women are unclear.

Rare ovarian tumors can cause increased male hormones in postmenopausal women; surgery is an effective treatment.

Hormone replacement therapy improves skin health and reduces aging signs in postmenopausal women.

β-estradiol slows hair growth in mice.

High doses of testosterone disrupt hormone levels and receptor expression in the uterus, affecting fertility.

Androgens and estrogens are crucial for male reproductive health, affecting hormone levels and tissue function.

Certain ESR1 gene variations may affect hormone levels and fat distribution in women with high male hormone levels.

Estetrol may help prevent hair loss and support hair growth in women.

The document concludes that sex hormones and related compounds have various effects on health, with both potential benefits and risks.

Both treatments reduced androgen levels and hair growth in women with hirsutism.

Estrogen increases a growth factor in hair cells which might affect hair loss.

The more lipophilic the progesterone derivative, the better it binds to androgen receptors and has antiandrogenic effects.

Postmenopausal virilization can be caused by ovarian hyperthecosis, treatable with surgery.

Anastrozole can cause increased testosterone, leading to symptoms like hair growth and thinning.

Topical estrogen helps hair growth in menopausal women with no major side effects.

Thorough evaluation is crucial for postmenopausal women with virilization to detect rare ovarian tumors.

Some hormone treatments might raise breast cancer risk, while others don't seem to.

The estrogen receptor pathway controls hair growth cycles and affects skin cell growth.

Sex steroid hormones are essential for reproductive health and overall well-being.

The combination therapy reduced hirsutism in women with PCOD and was well-tolerated.

Menopause and aging can affect women's quality of life and sexuality, but hormone therapies may help alleviate these issues.

Testosterone treatment may change estrogen receptor methylation in AFAB individuals.

A transman experienced lasting virilization symptoms after stopping testosterone, which were resolved with estradiol treatment.

A postmenopausal woman's virilization was caused by a rare ovarian tumor that was hard to detect but was successfully treated with surgery.

A 68-year-old woman developed male traits due to a tumor in her ovary, which was removed, returning her hormone levels to normal.

A woman's excessive hair growth and masculine features were due to a rare benign ovarian tumor and endometrial cancer, which improved after surgery.

Birth control pills increase certain receptor activities in female gerbil prostate glands and can lead to prostate changes.

Gender-affirming hormone therapy and surgery affect gut bacteria differently.

Oestrogen does not affect adrenal androgen levels in children and adolescents.

Hirsutism is excessive male-pattern hair growth in women, often treated cosmetically or with hormone therapy if contraception is also desired.